News

Google News
pharmacytimes. com > view > beyond-injections-the-rise-of-oral-glp-1-therapy

Beyond Injections: The Rise of Oral GLP-1 Therapy

8+ hour, 24+ min ago  (360+ words) Oral semaglutide delivers significant weight loss in OASIS trials, offering needle-free obesity therapy. Although injectable GLP-1 receptor agonists have demonstrated impressive efficacy, some patients remain hesitant to initiate therapy due to needle aversion, injection burden, or concerns regarding administration technique....

Symbols: glp-1s
@Pharmacy_Times
pharmacytimes. com > view > beyond-triple-therapy-how-pharmacists-can-identify-copd-patients-who-need-a-biologic

Beyond Triple Therapy: How Pharmacists Can Identify COPD Patients Who Need a Biologic

6+ hour, 34+ min ago  (384+ words) Monica Dougherty, Pharm D, BCACP, explains how the 2026 GOLD guideline updates use blood eosinophil counts to guide biologic therapy decisions for patients with COPD. Pharmacy Times: Can you please introduce yourself? Monica Dougherty, Pharm D, BCACP: My name is Monica…...

Symbols: nyse:azn,btc-usd,nasdaq:cntb
@Pharmacy_Times
pharmacytimes. com > view > automation-in-pharmacy-strategies-for-health-system-success

Automation in Pharmacy: Strategies for Health System Success

7+ hour, 10+ min ago  (631+ words) Key questions to address during the assessment include: Engaging frontline pharmacists and pharmacy technicians in this process is essential. These staff members have firsthand knowledge of daily friction points and are more likely to champion technology adoption when they have…...

Symbols: nyse:bdx
Google News
pharmacytimes. com > view > faqs-amid-the-ongoing-us-measles-outbreaks

FAQs Amid the Ongoing US Measles Outbreaks

13+ hour, 45+ min ago  (698+ words) This FAQ outlines current measles cases, key drivers of increasing cases, and the essential role pharmacists play in vaccination, patient counseling, case recognition, and combating vaccine misinformation. This FAQ was fact-checked by Adam James, Pharm D. Q1: What is the current status…...

@Pharmacy_Times
pharmacytimes. com > view > olezarsen-receives-fda-approval-to-reduce-triglycerides-risk-of-acute-pancreatitis-in-severe-hypertriglyceridemia

Olezarsen Receives FDA Approval to Reduce Triglycerides, Risk of Acute Pancreatitis in Severe Hypertriglyceridemia

16+ hour, 25+ min ago  (463+ words) The agent is to be used alongside diet adjustments in adult patients. The FDA approved olezarsen (Tryngolza; Ionis Pharmaceuticals) used with diet to reduce triglycerides and the risk of acute pancreatitis in adult patients with severe hypertriglyceridemia. With this approval,…...

Symbols: nasdaq:arwr,mir-93
@Pharmacy_Times
pharmacytimes. com > view > fda-approves-sacituzumab-govitecan-for-first-line-treatment-of-advanced-triple-negative-breast-cancer

FDA Approves Sacituzumab Govitecan for First-Line Treatment of Advanced Triple-Negative Breast Cancer

18+ hour, 39+ min ago  (581+ words) TNBC accounts for approximately 10% to 15% of all breast cancers and is associated with an aggressive clinical course, early recurrence, and poorer outcomes compared with other breast cancer subtypes. 2 Historically, treatment options for patients with advanced TNBC have been limited, particularly…...

Symbols: nasdaq:gild,nasdaq:kzia,6990.hk,btc-usd,eth-usd
@Pharmacy_Times
pharmacytimes. com > view > mckesson-ideashare-2026-why-independent-pharmacies-must-expand-clinical-services-now-according-to-health-mart-s-suzanne-feeney

Mc Kesson idea Share 2026: Why Independent Pharmacies Must Expand Clinical Services Now, According to Health Mart's Suzanne Feeney

19+ hour, 52+ min ago  (364+ words) Pharmacy Times: Can you please introduce yourself? Suzanne Feeney: Hi, I'm Suzanne Feeney. I am a pharmacist. I currently work as the senior director of pharmacy solutions with Health Mart. Pharmacy Times: With reimbursement cuts and pressures mounting, why is…...

Symbols: d05.S0,u11.S0,z74.S0,nxnr.si,fq7.S0,wj9.S0
Google News
pharmacytimes. com > view > drug-shortages-are-declining-but-persistent-supply-chain-vulnerabilities-continue-to-threaten-access

Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access

1+ week, 2+ day ago  (915+ words) While overall drug shortages declined in 2025, USP findings suggest that longstanding supply chain vulnerabilities continue to fuel persistent shortages across multiple therapeutic areas. USP's findings signify that persistent drug shortages are driven by broader structural weaknesses within the pharmaceutical supply…...

@Pharmacy_Times
pharmacytimes. com > view > start-with-the-statin-then-work-the-problem-mary-katherine-cheeley-s-framework-for-lipid-therapy-optimization

Start With the Statin, Then Work the Problem: Mary Katherine Cheeley's Framework for Lipid Therapy Optimization

1+ week, 2+ day ago  (356+ words) Cheeley takes listeners inside her clinical decision-making process'from statin intolerance to PCSK9 inhibitors to omega-3s'and explains why patient buy-in is as important as the prescription itself. We will get you on something'even if it's just a baby dose of it,…...

Symbols: acc.26
@Pharmacy_Times
pharmacytimes. com > view > drug-shortages-causes-consequences-and-mitigation

Drug Shortages: Causes, Consequences, and Mitigation

1+ week, 2+ day ago  (325+ words) Operational mitigation strategies must optimize inventory and distribution, as described in the Table. 2 Some institutions also use repackaging or allocation protocols to extend limited supplies equitably across patient populations. Conversion from intravenous to oral therapy, when clinically appropriate, can further…...

Symbols: nasdaq:drug